Gilead Sciences Inc Stock
Price
Target price
€60.82
€60.82
-0.050%
-0.03
-0.050%
€90.31
09:27 / Tradegate
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Stock / Biotechnology & Medical Research / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Gilead Sciences Inc Stock
There is nearly no change for the Gilead Sciences Inc stock today. Compared to yesterday it only changed by -€0.030.
With 9 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 90 € shows a positive potential of 47.98% compared to the current price of 60.82 € for Gilead Sciences Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Gilead Sciences Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | -0.050% | -2.107% | -9.152% | -22.007% | -16.781% | 12.435% | 5.496% |
| Exact Sciences | -7.340% | -8.132% | -4.464% | -5.469% | -20.050% | -50.506% | -34.936% |
| Incyte Corp. | -2.170% | -3.849% | -10.015% | -29.982% | -15.915% | -32.537% | -27.613% |
| Regeneron Pharmaceuticals Inc. | 0.670% | -1.120% | -6.562% | 15.386% | 4.100% | 105.699% | 165.070% |
Comments
Gilead Sciences, Inc. (NASDAQ: GILD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $105.00 price target on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at Mizuho from $101.00 to $90.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
